Probing the Evolution of Retained Austenite in TRIP Steel During Strain-Induced Transformation: A Multitechnique Investigation

X-ray diffraction analysis, magnetic force microscopy, and the saturation magnetization method have been employed to study the evolution of the percentage and size of retained austenite (RA) particles during strain-induced transformation in a transformation-induced plasticity (TRIP) steel. A low-alloy TRIP-700 steel with nominal composition Fe-0.2C-0.34Si-1.99Mn-1Al (mass%) was subjected to interrupted tensile testing at strain levels of 0–22% and the microstructure subsequently studied. The results of the three experimental techniques were in very good agreement regarding the estimated austenite volume fraction and its evolution with strain. Furthermore, this multitechnique approach revealed that the average particle size of RA reduced as the applied strain was increased, suggesting that larger particles are less stable and more susceptible to strain-induced phase transformation. Such experimentally determined evolution of the austenite size with strain could serve as an input to kinetic models that aim to predict the strain-induced transformation in low-alloy TRIP steels

Evaluation of elastic modulus and hardness of highly inhomogeneous materials by nanoindentation

The experimental and numerical techniques for evaluation of mechanical properties of highly inhomogeneous materials are discussed. The techniques are applied to coal as an example of such a material. Characterization of coals is a very difficult task because they are composed of a number of distinct organic entities called macerals and some amount of inorganic substances along with internal pores and cracks. It is argued that to avoid the influence of the pores and cracks, the samples of the materials have to be prepared as very thin and very smooth sections, and the depth-sensing nanoindentation (DSNI) techniques has to be employed rather than the conventional microindentation. It is shown that the use of the modern nanoindentation techniques integrated with transmitted light microscopy is very effective for evaluation of elastic modulus and hardness of coal macerals. However, because the thin sections are glued to the substrate and the glue thickness is approximately equal to the thickness of the section, the conventional DSNI techniques show the effective properties of the section/substrate system rather than the properties of the material. As the first approximation, it is proposed to describe the sample/substrate system using the classic exponential weight function for the dependence of the equivalent elastic contact modulus on the depth of indentation. This simple approach allows us to extract the contact modulus of the material constitutes from the data measured on a region occupied by a specific component of the material. The proposed approach is demonstrated on application to the experimental data obtained by Berkovich nanoindentation with varying maximum depth of indentation

Mechanistic population pharmacokinetics of total and unbound paclitaxel for a new nanodroplet formulation versus Taxol in cancer patients.

PURPOSE: Our objectives were (1) to compare the disposition and in vivo release of paclitaxel between a tocopherol-based Cremophor-free formulation (Tocosol Paclitaxel) and Cremophor EL-formulated paclitaxel (Taxol) in human subjects, and (2) to develop a mechanistic model for unbound and total paclitaxel pharmacokinetics. METHODS: A total of 35 patients (average +/- SD age: 59 +/-13 years) with advanced non-hematological malignancies were studied in a randomized two-way crossover trial. Patients received 175 mg/m(2) paclitaxel as 15 min (Tocosol Paclitaxel) or 3 h (Taxol) intravenous infusion in each study period. Paclitaxel concentrations were determined by LC-MS/MS in plasma ultrafiltrate and whole blood. NONMEM VI was used for population pharmacokinetics. RESULTS: A linear disposition model with three compartments for unbound paclitaxel and a one-compartment model for Cremophor were applied. Total clearance of unbound paclitaxel was 845 L/h (variability: 25% CV). The prolonged release with Tocosol Paclitaxel was explained by the limited solubility of unbound paclitaxel of 405 ng/mL (estimated) in plasma. The 15 min Tocosol Paclitaxel infusion yielded a mean time to 90% cumulative input of 1.14 +/- 0.16 h. Tocosol Paclitaxel was estimated to release 9.8% of the dose directly into the deep peripheral compartment. The model accounted for the presence of drug-containing nanodroplets in blood. CONCLUSIONS: Population pharmacokinetic analysis indicated linear disposition and a potentially higher bioavailability of unbound paclitaxel following Tocosol Paclitaxel administration due to direct release at the target site. The prolonged release of Tocosol Paclitaxel supports 15 min paclitaxel infusions. This mechanistic model may be important for development of prolonged release formulations that distribute in and from the systemic circulation.Journal ArticleMulticenter StudyRandomized Controlled TrialResearch Support, Non-U.S. Gov'tinfo:eu-repo/semantics/publishe